Cargando…

HUNK phosphorylates EGFR to regulate breast cancer metastasis

Epidermal growth factor receptor (EGFR) is commonly over-expressed in metastatic breast cancer yet metastatic breast cancer is generally resistant to anti-EGFR therapies, and the mechanism for resistance to EGFR inhibitors in this setting is not fully understood. Hormonally up-regulated neu-associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Carly B., Phelps-Polirer, Kendall, Dingle, Ivan P., Williams, Christina J., Rhett, Matthew J., Eblen, Scott T., Armeson, Kent, Hill, Elizabeth G., Yeh, Elizabeth S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989402/ https://www.ncbi.nlm.nih.gov/pubmed/31597954 http://dx.doi.org/10.1038/s41388-019-1046-5

Ejemplares similares

Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis
por: Williams, Carly B., et al.
Publicado: (2021)

HUNK Phosphorylates Rubicon to Support Autophagy
por: Zambrano, Joelle N., et al.
Publicado: (2019)

Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer
por: Phelps-Polirer, Kendall, et al.
Publicado: (2016)

HUNK Signaling in Metastatic Breast Cancer
por: Dilday, Tinslee, et al.
Publicado: (2020)

HUNK Gene Alterations in Breast Cancer
por: Ramos-Solis, Nicole, et al.
Publicado: (2022)

Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase
por: Zambrano, Joelle N., et al.
Publicado: (2018)

Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors
por: Yeh, Elizabeth S., et al.
Publicado: (2014)

Hunk/Mak-v is a negative regulator of intestinal cell proliferation
por: Reed, Karen R, et al.
Publicado: (2015)

Generalized Granuloma Annulare Associated With Dupilumab Therapy
por: Phelps-Polirer, Kendall, et al.
Publicado: (2022)

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1
por: Han, Xiaoqi, et al.
Publicado: (2023)

Connexin 43 in the development and progression of breast cancer: What's the connection? (Review)
por: Phillips, Stephanie L., et al.
Publicado: (2017)

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer
por: Rutkovsky, Alexandria C., et al.
Publicado: (2019)

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
por: Magkou, Christina, et al.
Publicado: (2008)

The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response
por: Rhett, J. Matthew, et al.
Publicado: (2018)

EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer
por: Kang, JiHoon, et al.
Publicado: (2022)

Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling
por: Lonic, Ana, et al.
Publicado: (2021)

Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration
por: Yeh, Elizabeth S., et al.
Publicado: (2017)

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
por: Williams, Carly Bess, et al.
Publicado: (2016)

PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
por: Slack-Davis, Jill K., et al.
Publicado: (2003)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Protein Phosphorylation Profiling Using an In Situ Proximity Ligation Assay: Phosphorylation of AURKA-Elicited EGFR-Thr654 and EGFR-Ser1046 in Lung Cancer Cells
por: Chen, Tzu-Chi, et al.
Publicado: (2013)

Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling
por: He, Yongfeng, et al.
Publicado: (2016)

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
por: Wang, Fen, et al.
Publicado: (2012)

Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845
por: Sato, Ken-ichi
Publicado: (2013)

Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH
por: Swiatnicki, Matthew R., et al.
Publicado: (2022)

Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
por: Liu, Yuying, et al.
Publicado: (2013)

Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity
por: Zhou, Cefan, et al.
Publicado: (2022)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

Temperature sensitive liposomes combined with thermal ablation: Effects of duration and timing of heating in mathematical models and in vivo
por: Rossmann, Christian, et al.
Publicado: (2017)

EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1
por: Ando, Toshinori, et al.
Publicado: (2021)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

Special Issue: Cancer Metastasis and Therapeutic Resistance
por: Yeh, Elizabeth S.
Publicado: (2023)

BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
por: Fu, Wenyan, et al.
Publicado: (2019)

Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas
por: Rai, Ashutosh, et al.
Publicado: (2021)

Targeting Chromatin Remodeling for Cancer Therapy
por: Kaur, Jasmine, et al.
Publicado: (2019)

SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
por: Thomas, J. Terrig, et al.
Publicado: (2016)

Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
por: Grek, Christina L, et al.
Publicado: (2015)

EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR
por: Ishikawa, Kouki, et al.
Publicado: (2012)

Diesel exhaust increases EGFR and phosphorylated C-terminal Tyr 1173 in the bronchial epithelium
por: Pourazar, Jamshid, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9e5bfijqunhpgk83c44sclf0or